Oculusgen (Ologen) Glaucoma MMC Control in Estonia

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the safety and effectiveness between ologen collagen matrix and mitomycin-C (MMC) in glaucoma surgery.

The ologen collagen matrix implantation procedure is same as traditional trabeculectomy except implant the ologen collagen matrix on the top of sclera flap after one loose stich the sclera flap. The MMC application is as the standard.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pro Top & Mediking Company Limited
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• Max anti glaucoma medication failed,

Exclusion Criteria:

• Age less than 18, woman in pregnant, hemodialysis patient